Wiesner A, Zagrodzki P, Gawalska A, Pasko P
Clin Pharmacokinet. 2024; 63(6):773-818.
PMID: 38807006
PMC: 11222276.
DOI: 10.1007/s40262-024-01377-0.
Pitman S, Hoang U, Wi C, Alsheikh M, Hiner D, Percival K
Antibiotics (Basel). 2019; 8(3).
PMID: 31370320
PMC: 6784105.
DOI: 10.3390/antibiotics8030108.
Holm J, Eiermann B, Eliasson E, Mannheimer B
Eur J Clin Pharmacol. 2014; 70(11):1375-83.
PMID: 25190295
DOI: 10.1007/s00228-014-1745-3.
Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P
Antimicrob Agents Chemother. 1999; 43(5):1067-71.
PMID: 10223915
PMC: 89112.
DOI: 10.1128/AAC.43.5.1067.
Mueller B, Brierton D, Abel S, Bowman L
Antimicrob Agents Chemother. 1994; 38(9):2101-5.
PMID: 7811026
PMC: 284691.
DOI: 10.1128/AAC.38.9.2101.
Drug interactions with antacids. Mechanisms and clinical significance.
Sadowski D
Drug Saf. 1994; 11(6):395-407.
PMID: 7727050
DOI: 10.2165/00002018-199411060-00002.
Absorption interactions with fluoroquinolones. 1995 update.
Lomaestro B, Bailie G
Drug Saf. 1995; 12(5):314-33.
PMID: 7669261
DOI: 10.2165/00002018-199512050-00004.
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Monk J, Price A, Benfield P, Todd P, Ward A
Drugs. 1988; 35(4):373-447.
PMID: 3292209
DOI: 10.2165/00003495-198835040-00003.
Randomized, double-blind comparison of ciprofloxacin and trimethoprim-sulfamethoxazole for complicated urinary tract infections.
Allais J, Preheim L, Cuevas T, Roccaforte J, Mellencamp M, Bittner M
Antimicrob Agents Chemother. 1988; 32(9):1327-30.
PMID: 3195995
PMC: 175861.
DOI: 10.1128/AAC.32.9.1327.
Quinolones and the gastrointestinal tract.
Murray B
Eur J Clin Microbiol Infect Dis. 1989; 8(12):1093-101.
PMID: 2695330
DOI: 10.1007/BF01975176.
Fluoroquinolone antimicrobial agents.
Wolfson J, Hooper D
Clin Microbiol Rev. 1989; 2(4):378-424.
PMID: 2680058
PMC: 358131.
DOI: 10.1128/CMR.2.4.378.
Quinolone antimicrobial agents: adverse effects and bacterial resistance.
Wolfson J
Eur J Clin Microbiol Infect Dis. 1989; 8(12):1080-92.
PMID: 2559848
DOI: 10.1007/BF01975175.
Inhibition of norfloxacin absorption by antacids.
Nix D, Wilton J, Ronald B, Distlerath L, Williams V, Norman A
Antimicrob Agents Chemother. 1990; 34(3):432-5.
PMID: 2334155
PMC: 171610.
DOI: 10.1128/AAC.34.3.432.
Clinical pharmacokinetics of ciprofloxacin.
Guay D, Rotschafer J
Clin Pharmacokinet. 1990; 19(6):434-61.
PMID: 2292168
DOI: 10.2165/00003088-199019060-00003.
Effects of antacids on the clinical pharmacokinetics of drugs. An update.
Gugler R, Allgayer H
Clin Pharmacokinet. 1990; 18(3):210-9.
PMID: 1969784
DOI: 10.2165/00003088-199018030-00003.
Effect of antacid on absorption of the quinolone lomefloxacin.
Shimada J, Shiba K, Oguma T, Miwa H, Yoshimura Y, Nishikawa T
Antimicrob Agents Chemother. 1992; 36(6):1219-24.
PMID: 1329615
PMC: 190321.
DOI: 10.1128/AAC.36.6.1219.
